Zobrazeno 1 - 7
of 7
pro vyhledávání: ''
Autor:
Richard W. Orrell, David Hilton-Jones, Judith Hudson, Hanns Lochmüller, Maggie Williams, Teresinha Evangelista, Libby Wood, Michela Guglieri, Debbie Smith, Peter Lunt, Fiona Norwood, Tracey Willis, Karen Rafferty, Roberto Fernández-Torrón
Publikováno v:
Journal of Neurology
Facioscapulohumeral dystrophy (FSHD) is a rare inherited neuromuscular disease estimated to affect 1/15,000 people. Through basic research, remarkable progress has been made towards the development of targeted therapies. Patient identification, throu
Autor:
Ludwig Kappos, Michaela Andělová, Christoph Stippich, Michael Amann, Till Sprenger, Ernst-Wilhelm Radue, Simon Pezold, Katrin Weier, Yvonne Naegelin, Ketut Fundana, Philippe C. Cattin
Publikováno v:
Journal of Neurology. 263:1364-1374
Spinal cord (SC) atrophy is an important contributor to the development of disability in many neurological disorders including multiple sclerosis (MS). To assess the spinal cord atrophy in clinical trials and clinical practice, largely automated meth
Autor:
Keith Wheatley, Michael A. Burdon, Arul Sivaguru, Andrew S. Jacks, Timothy D Matthews, Alexandra J Sinclair, Basil Sharrack, A. K. Ball, Alexandra Furmston, Andrew Howman, Steven Howell, Mark Lawden, M. Brendan Davies, Carl E Clarke
Publikováno v:
Journal of Neurology. 258:874-881
The cause of idiopathic intracranial hypertension (IIH) remains unknown, and no consensus exists on how patients should be monitored and treated. Acetazolamide is a common treatment but has never been examined in a randomised controlled trial. The ob
Autor:
Martin B. Delatycki, Louise A. Corben, Veronica Collins, Catherine L Wilson, Geneieve Tai, Andrew Churchyard
Publikováno v:
Journal of Neurology. 257:518-523
Friedreich Ataxia (FRDA) is the commonest inherited ataxia. Clinical trials of pharmaceuticals are increasingly being conducted in this condition. This requires the most accurate outcome measures to enable trials to be conducted with a minimum number
Publikováno v:
Journal of neurology. 259(7)
Precise analysis of stroke subtypes is important for clinical treatment decisions, the prognostic evaluation of patients, as well as defining stroke populations in clinical studies. The TOAST classification is the most widely used and approved form f
Publikováno v:
Journal of neurology. 259(4)
Walking difficulties are common in neurological and other disorders, as well as among the elderly. There is a need for reliable and valid instruments for measuring walking difficulties in everyday life since existing gait tests are clinician rated an
Autor:
Gilles Edan, Emmanuelle Leray, Laurent Flet, Hervé Allain, Olivia Guillard, Elisabeth Polard, Loïc Javaudin
Publikováno v:
Journal of neurology. 257(6)
Fatigue is one of the most common and disabling symptoms of multiple sclerosis (MS) and has a significant, often underestimated, impact on patients' quality of life. Current management is mainly symptomatic. 3,4-diaminopyridine (3,4-DAP) is a voltage